Results
|
|
2561.
|
|
|
|
2562.
|
|
|
|
2563.
|
|
|
|
2564.
|
|
|
|
2565.
|
|
|
|
2566.
|
|
|
|
2567.
|
|
|
|
2568.
|
NET-02 trial protocol: a multicentre, randomised, parallel group, open-label, phase II, single-stage selection trial of liposomal irinotecan (nal-IRI) and 5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line therapy in patients with progressive poorly differentiated extrapulmonary neuroendocrine carcinoma (NEC). [electronic resource] by
- Craig, Zoe
- Swain, Jayne
- Batman, Emma
- Wadsley, Jonathan
- Reed, Nicholas
- Faluyi, Olusola
- Cave, Judith
- Sharma, Rohini
- Chau, Ian
- Wall, Lucy
- Lamarca, Angela
- Hubner, R
- Mansoor, Wasat
- Sarker, Debashis
- Meyer, Tim
- Cairns, David A
- Howard, Helen
- Valle, Juan W
- McNamara, Mairéad G
Producer: 20210413
In:
BMJ open vol. 10
Availability: No items available.
|
|
|
2569.
|
|
|
|
2570.
|
|
|
|
2571.
|
|
|
|
2572.
|
|
|
|
2573.
|
|
|
|
2574.
|
|
|
|
2575.
|
|
|
|
2576.
|
|
|
|
2577.
|
|
|
|
2578.
|
|
|
|
2579.
|
|
|
|
2580.
|
|